Processing PDF: /home/ngobiro/projects/pngobiro.github.io/colleges/kmtc/diploma/Diploma in Kenya Registered Community Health Nursing/Year 1/Cardiovascular Nursing/03_Common_Cardiovascular_Disorders/02_Hypertension/pdfs/2014-JNC-8-Hypertension.pdf
Starting PDF processing...
PDF processing started. ID: 2025_06_28_a1f43d193632bfd093c6g
Polling PDF status (ID: 2025_06_28_a1f43d193632bfd093c6g)...
Attempt 1: Status = completed, Progress = 100.0%
PDF processing completed successfully.
Fetching MMD result (ID: 2025_06_28_a1f43d193632bfd093c6g)...

--- Converted MMD Start ---
JNC 8 Hypertension Guideline Algorithm
![](https://cdn.mathpix.com/cropped/2025_06_28_a1f43d193632bfd093c6g-1.jpg?height=1831&width=2489&top_left_y=35&top_left_x=0)
\begin{tabular}{|l|l|}
\hline \multicolumn{2}{|c|}{Compelling Indications} \\
\hline Indication & Treatment Choice \\
\hline Heart Failure & ACEI/ARB + BB + diuretic + spironolactone \\
\hline Post-MI/Clinical CAD & ACEI/ARB AND BB \\
\hline CAD & ACEI, BB, diuretic, CCB \\
\hline Diabetes & ACEI/ARB, CCB, diuretic \\
\hline CKD & ACEI/ARB \\
\hline Recurrent stroke prevention & ACEI, diuretic \\
\hline Pregnancy & labetolol (first line), nifedipine, methyldopa \\
\hline
\end{tabular}

\section*{Hypertension Treatment}

Beta-1 Selective Beta-blockers - possibly safer in patients with COPD, asthma, diabetes, and peripheral vascular disease:
- metoprolol
- bisoprolol
- betaxolol
- acebutolol
\begin{tabular}{|l|l|l|}
\hline Drug Class & Agents of Choice & Comments \\
\hline Diuretics & \begin{tabular}{l}
HCTZ $12.5-50 \mathrm{mg}$, chlorthalidone $12.5-25 \mathrm{mg}$, indapamide $1.25-2.5 \mathrm{mg}$ triamterene 100 mg \\
K+ sparing - spironolactone $25-50 \mathrm{mg}$, amiloride $5-10 \mathrm{mg}$, triamterene 100 mg \\
furosemide $20-80 \mathrm{mg}$ twice daily, torsemide $10-40 \mathrm{mg}$
\end{tabular} & \begin{tabular}{l}
Monitor for hypokalemia \\
Most SE are metabolic in nature \\
Most effective when combined w/ ACEI \\
Stronger clinical evidence w/chlorthalidone \\
Spironolactone - gynecomastia and hyperkalemia \\
Loop diuretics may be needed when GFR $<40 \mathrm{~mL} / \mathrm{min}$
\end{tabular} \\
\hline ACEI/ARB & \begin{tabular}{l}
ACEI: lisinopril, benazapril, fosinopril and quinapril $10-40 \mathrm{mg}$, ramipril 510 mg , trandolapril $2-8 \mathrm{mg}$ \\
ARB: candesartan $8-32 \mathrm{mg}$, valsartan $80-320 \mathrm{mg}$, losartan $50-100 \mathrm{mg}$, olmesartan $20-40 \mathrm{mg}$, telmisartan $20-80 \mathrm{mg}$
\end{tabular} & \begin{tabular}{l}
SE: Cough (ACEI only), angioedema (more with ACEI), hyperkalemia \\
Losartan lowers uric acid levels; candesartan may prevent migraine headaches
\end{tabular} \\
\hline Beta-Blockers & metoprolol succinate $50-100 \mathrm{mg}$ and tartrate $50-100 \mathrm{mg}$ twice daily, nebivolol $5-10 \mathrm{mg}$, propranolol $40-120 \mathrm{mg}$ twice daily, carvedilol $6.25-25 \mathrm{mg}$ twice daily, bisoprolol $5-10 \mathrm{mg}$, labetalol $100-300 \mathrm{mg}$ twice daily, & \begin{tabular}{l}
Not first line agents - reserve for post-MI/CHF \\
Cause fatigue and decreased heart rate \\
Adversely affect glucose; mask hypoglycemic awareness
\end{tabular} \\
\hline Calcium channel blockers & Dihydropyridines: amlodipine $5-10 \mathrm{mg}$, nifedipine ER $30-90 \mathrm{mg}$, Non-dihydropyridines: diltiazem ER $180-360 \mathrm{mg}$, verapamil $80-120 \mathrm{mg} 3$ times daily or ER $240-480 \mathrm{mg}$ & \begin{tabular}{l}
Cause edema; dihydropyridines may be safely combined w/ B-blocker \\
Non-dihydropyridines reduce heart rate and proteinuria
\end{tabular} \\
\hline Vasodilators & \begin{tabular}{l}
hydralazine $25-100 \mathrm{mg}$ twice daily, minoxidil $5-10 \mathrm{mg}$ \\
terazosin $1-5 \mathrm{mg}$, doxazosin $1-4 \mathrm{mg}$ given at bedtime
\end{tabular} & \begin{tabular}{l}
Hydralazine and minoxidil may cause reflex tachycardia and fluid retention - usually require diuretic + B-blocker \\
Alpha-blockers may cause orthostatic hypotension
\end{tabular} \\
\hline Centrally-acting Agents & \begin{tabular}{l}
clonidine $0.1-0.2 \mathrm{mg}$ twice daily, methyldopa $250-500 \mathrm{mg}$ twice daily \\
guanfacine $1-3 \mathrm{mg}$
\end{tabular} & Clonidine available in weekly patch formulation for resistant hypertension \\
\hline
\end{tabular}
--- Converted MMD End ---
